Mometasone furoate and Cyclosporine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mometasone furoate (mometasone furoate) and Cyclosporine (cyclosporine). Common drug interactions include skin burning sensation among females and drug hypersensitivity among males.
The phase IV clinical study analyzes what interactions people have when they take Mometasone furoate and Cyclosporine. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.
What is Mometasone furoate?
Mometasone furoate has active ingredients of mometasone furoate. It is often used in allergies. eHealthMe is studying from 11,728 Mometasone furoate users. Check the latest studies of Mometasone furoate.
What is Cyclosporine?
Cyclosporine has active ingredients of cyclosporine. It is often used in psoriasis. eHealthMe is studying from 58,714 Cyclosporine users. Check the latest studies of Cyclosporine.
78 people who take Mometasone furoate and Cyclosporine together, and have interactions are studied.

What are the common drug interactions of Mometasone Furoate and Cyclosporine, by gender? *:
female:
- Skin burning sensation
- Temperature regulation disorder (body is unable to maintain temperature)
- Urinary tract infection
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Balance disorder
- Cardiac disorder
- Dyspnoea (difficult or laboured respiration)
- Ear congestion
- Faeces discoloured
- Nausea (feeling of having an urge to vomit)
male:
- Drug hypersensitivity
- Drug ineffective
- Weight decreased
- Weight increased
- Cellulitis (infection under the skin)
- Myocarditis (inflammation of heart muscle myocardium)
- Oxygen saturation decreased
- Thrombosis (formation of a blood clot inside a blood vessel)
- Chest pain
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
What are the common drug interactions of Mometasone Furoate and Cyclosporine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Drug ineffective
- Ocular hypertension (intraocular pressure higher than normal)
- Abnormal behaviour
- Aggression
10-19:
- Influenza
- Respiratory tract infection
- Abdominal pain upper
- Dilatation intrahepatic duct acquired
- Dry skin
- Dysgeusia (disorder of the sense of taste)
- Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
- Glomerulosclerosis (a hardening of the glomerulus in the kidney)
- Hepatotoxicity (chemical-driven liver damage)
- Injection site irritation
20-29:
- Insomnia (sleeplessness)
- Pruritus (severe itching of the skin)
- Skin exfoliation (removal of the oldest dead skin cells)
- Depression
- Electric shock
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Herpes simplex (herpes simplex is a common viral infection)
- Infection
- Oedema (fluid collection in tissue)
30-39:
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Dizziness
- Gastrointestinal infection (infection of stomach and intestine)
- Intestinal obstruction
- Pain
- Pneumonia
40-49:
- Otitis externa fungal (fungal infection of external ear)
- Pain
- Prostatomegaly (enlargement of the prostate)
- Pruritus (severe itching of the skin)
- Rash
- Scar
- Secondary hypertension (elevated blood pressure that results from an underlying, identifiable, often correctable cause)
- Skin irritation
- Skin plaque (red, scaly patches to appear on the skin)
- Testicular swelling (swelling of testes)
50-59:
- Arthralgia (joint pain)
- Confusional state
- Dizziness
- Hot flush (sudden feelings of heat)
- Inflammation
- Injection site bruising
- Injection site erythema (redness at injection site)
- Injection site haemorrhage (bleeding from injection site)
- Injection site induration
- Injection site warmth
60+:
- Drug hypersensitivity
- Nasopharyngitis (inflammation of the nasopharynx)
- Dizziness
- Eye swelling
- Feeling cold
- Fungal infection
- Head injury
- Immune system disorder
- Increased viscosity of bronchial secretion
- Influenza like illness
What are the existing conditions these people have? *
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 15 people, 19.23%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 15.38%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 10.26%
- Nausea (feeling of having an urge to vomit): 8 people, 10.26%
- Glomerulonephritis Membranous (nephritis with inflammation of the capillary loops in the renal glomeruli): 7 people, 8.97%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 7.69%
- Thrombocytopenia (decrease of platelets in blood): 5 people, 6.41%
- Hypokalemia (low potassium): 5 people, 6.41%
- Febrile Neutropenia (fever with reduced white blood cells): 5 people, 6.41%
- High Blood Pressure: 5 people, 6.41%
* Approximation only. Some reports may have incomplete information.
Do you take Mometasone furoate and Cyclosporine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mometasone furoate (11,728 reports)
- Cyclosporine (58,714 reports)
Browse all drug interactions of Mometasone furoate and Cyclosporine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mometasone furoate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cyclosporine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mometasone furoate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cyclosporine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on mometasone furoate and cyclosporine (the active ingredients of Mometasone furoate and Cyclosporine, respectively), and Mometasone furoate and Cyclosporine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Urinary Incontinence in Lisdexamfetamine Dimesylate, how severe and when it was recovered? - 2 seconds ago
- Could Rabeprazole cause Toxic Encephalopathy? - 4 seconds ago
- Cardiac Ventricular Thrombosis and Haemoglobin Decreased - 10 seconds ago
- Could Metrogel cause Death? - 20 seconds ago
- Exposed Bone In Jaw and drugs of ingredients of ramipril - 29 seconds ago
- Exforge vs. Vytorin, side effect and effectiveness comparison - 29 seconds ago
- Head Injury and Hyperkalemia - 30 seconds ago
- Urinary Tract Infection and Dyspnea Exertional - 30 seconds ago
- Could Fludara cause Lung Abscess? - 35 seconds ago
- Pantoprazole and Fibromyalgia for Women aged 50-59 - 39 seconds ago